← Back to all trials
Not Yet Recruiting
NCT05678283
A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
Conditions: Advanced Solid Tumors
Sex: Male
Ages: 18 Years – N/A
Phase: PHASE1
Enrollment: 8
Sponsor: Bristol-Myers Squibb
Location: Spain
Summary
The purpose of this study is to assess the absorption, metabolism, and elimination of CC-90010 and its metabolites following a single oral dose of radiolabeled CC-90010 in participants with advanced solid tumors.
Eligibility Criteria
Inclusion Criteria:Males ≥ 18 years of ageHas histological or cytological confirmation of advanced solid tumors including those who have progressed on standard anticancer therapy or for whom no other approved conventional therapy existsEastern Cooperative Oncology Group Performance Status (ECOG PS) of 0 to 1Exclusion Criteria:Persistent diarrhea National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Grade ≥ 2History of concurrent second cancers requiring active and ongoing systemic treatmentOther protocol-defined inclusion/exclusion criteria apply
Source: ClinicalTrials.gov (NCT05678283). StuddyBuddy aggregates publicly available trial information.
